Combination HRT raises women's risk of lung cancer

02/25/2010 | Reuters

Hormone replacement therapy containing estrogen and progestin increases the risk of lung cancer in women, according to study data. Women who used the combination HRT for 10 years or more were almost 50% more likely to be diagnosed with lung cancer compared with nonusers, even after taking into consideration age and smoking history.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA